BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

324 related articles for article (PubMed ID: 6980047)

  • 1. Suppression of cell-mediated antitumor immunity by complete Freund's adjuvant.
    Koyama S; Yoshioka T; Sakita T
    Cancer Res; 1982 Aug; 42(8):3215-9. PubMed ID: 6980047
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A myeloid cell population induced by Freund adjuvant suppresses T-cell-mediated antitumor immunity.
    Wang Z; Jiang J; Li Z; Zhang J; Wang H; Qin Z
    J Immunother; 2010; 33(2):167-77. PubMed ID: 20145547
    [TBL] [Abstract][Full Text] [Related]  

  • 3. T cell-mediated immunity to oncornavirus-induced tumors. III. Specific and nonspecific suppression in tumor-bearing mice.
    Plater C; Debré P; Leclerc JC
    Eur J Immunol; 1981 Jan; 11(1):39-44. PubMed ID: 6452278
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytotoxic T-cell-mediated antitumor effect of levamisole against murine syngeneic fibrosarcoma.
    Gomi K; Morimoto M; Nomoto K
    Cancer Res; 1982 Oct; 42(10):4197-202. PubMed ID: 6980702
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adjuvant regulation of T cell function.
    Reinisch CL; Gleiner NA; Schlossman SF
    J Immunol; 1976 Mar; 116(3):710-5. PubMed ID: 1082892
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of Nocardia rubra cell wall skeleton on T-cell-mediated cytotoxicity in mice bearing syngeneic sarcoma.
    Kawase I; Uemiya M; Yoshimoto T; Ogura T; Hirao F; Yamamura Y
    Cancer Res; 1981 Feb; 41(2):660-6. PubMed ID: 6969630
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of surgical removal and effect of levamisole on cytotoxic T-cell-mediated antitumor immunity in mice.
    Gomi K; Morimoto M; Nomoto K
    Cancer Res; 1983 Nov; 43(11):5120-5. PubMed ID: 6604572
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early suppression with late acceleration of syngeneic tumor growth by Freund's adjuvant.
    Cruse JM
    Z Immunitatsforsch Allerg Klin Immunol; 1967 Feb; 132(2):196-201. PubMed ID: 4230697
    [No Abstract]   [Full Text] [Related]  

  • 9. Differing contribution of various effector cells in the elimination of syngeneic or allogeneic cells.
    Matsumoto T; Himeno K; Mitani M; Mori K; Miake S; Nomoto K
    J Clin Lab Immunol; 1986 Feb; 19(2):83-9. PubMed ID: 3083105
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of protective immunity against bacterial and viral infections in tumor-bearing mice coincident with suppression of tumor immunity.
    Bonventre PF; Nickol AD; Ball EJ; Michael JG; Bubel HC
    J Reticuloendothel Soc; 1982 Jul; 32(1):25-35. PubMed ID: 6290658
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Induction of immunoregulatory T cells by adjuvant.
    Reinisch CL
    Isr J Med Sci; 1978 Jan; 14(1):89-97. PubMed ID: 305433
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-tumor cytostatic mechanism and delayed-type hypersensitivity against a syngeneic murine tumor. Comparison between neonatally thymectomized mice and congenitally athymic nude mice.
    Mitani M; Mori K; Himeno K; Nomoto K
    J Immunol; 1989 Mar; 142(6):2148-54. PubMed ID: 2493508
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential activation of cytotoxic and suppressor T cells against syngeneic tumors in the mouse.
    Yamauchi K; Fujimoto S; Tada T
    J Immunol; 1979 Oct; 123(4):1653-8. PubMed ID: 90095
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Host reactivity against clonable tumor cells and the total tumor cell population, studied in a syngeneic murine lymphoma system.
    Gjedde SB
    Acta Pathol Microbiol Immunol Scand C; 1983 Apr; 91(2):101-8. PubMed ID: 6349250
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Enhancement of T cell-mediated immune responses in KMT-17-bearing rats by treatment with bleomycin].
    Xu ZY
    Hokkaido Igaku Zasshi; 1987 Mar; 62(2):279-88. PubMed ID: 2440789
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro induction of cytotoxicity against syngeneic mastocytoma and its suppression by spleen and thymus cells from tumor-bearing mice.
    Takei F; Levy JG; Kilburn DG
    J Immunol; 1976 Feb; 116(2):288-93. PubMed ID: 814160
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Matching of chemotherapy to mouse strain and lymphoid tumor type to prevent tumor-induced suppression of specific T- and B-cell functions.
    Faanes RB; Merluzzi VJ; Williams N; Tarnowski GS; Ralph P
    Cancer Res; 1979 Nov; 39(11):4564-74. PubMed ID: 315269
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Complete Freund's adjuvant-induced T cells prevent the development and adoptive transfer of diabetes in nonobese diabetic mice.
    Qin HY; Sadelain MW; Hitchon C; Lauzon J; Singh B
    J Immunol; 1993 Mar; 150(5):2072-80. PubMed ID: 8436836
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulatory role of IgE-binding factors from rat T lymphocytes. IV. Formation of IgE-binding factors in rats treated with complete Freund's adjuvant.
    Hirashima M; Yodoi J; Ishizaka K
    J Immunol; 1980 Nov; 125(5):2154-60. PubMed ID: 6968774
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adjuvant-induced thymus-derived suppressor cells of cell-mediated tumour immunity.
    Glaser M
    Nature; 1978 Oct; 275(5681):654-6. PubMed ID: 212680
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 17.